Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04467372 · ClinicalTrials.gov registry record · NA
Tart Cherry Supplementation & Gut Microbiome and Inflammation
A NA study of Sleep and Inflammation, sponsored by Ohio University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04467372: Completed NA study of Sleep and Inflammation, sponsored by Ohio University.
NCT04467372 is a NA study of Sleep and Inflammation that has completed, run by Ohio University. The registered enrollment target is 70 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04467372, a NA study of Sleep and Inflammation, has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the realm of inflammation research because sugar is known to increase the inflammatory response. The pill form of cherry supplementation has no added sugar and is naturally low in sugar (\< 1g) while the juice form is higher from added sugar. Recent work indicates tart cherry consumption can change gut microbiota, which may modify inflammation. The purpose of this study is to look at the effects of taking a cherry supplement, either in capsule or juice form, on the gut microbiome, inflammation, and health-related variables such as blood pressure, glucose regulation and sleep quality.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Tart cherry juice concentrate
- DIETARY_SUPPLEMENT Juice placebo
- DIETARY_SUPPLEMENT Freeze dried tart cherry powder
- DIETARY_SUPPLEMENT Capsule placebo
Study Locations (1)
Ohio
- Ohio University Exercise Physiology Lab - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
What the finished NCT04467372 record still lists
NCT04467372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 4 interventions - of which Tart cherry juice concentrate is the first listed.
NCT04467372 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04467372 about?
NCT04467372 is a clinical study titled "Tart Cherry Supplementation & Gut Microbiome and Inflammation". There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the re...
What is the current status of trial NCT04467372?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2019-03-18. Estimated completion is 2021-07-01.
What conditions does trial NCT04467372 study?
This clinical trial studies the following conditions: Sleep, Inflammation, Glucose Regulation.
What interventions are being tested in trial NCT04467372?
The interventions under investigation include: Tart cherry juice concentrate (DIETARY_SUPPLEMENT), Juice placebo (DIETARY_SUPPLEMENT), Freeze dried tart cherry powder (DIETARY_SUPPLEMENT), Capsule placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04467372?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04467372 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04467372's enrollment target sits among peer trials
70 82nd of 151 higher than 68 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI